Padrón work started at Cambridge´s MRC Laboratory of Molecular Biology. Padrón founded I.V.I.C.´s Center of Structural Biology, where he was an International Research Scholar of Howard Hughes Medical Institute. His group found by cryo-electron microscopy that in thick filaments of tarantula muscle the two heads form the myosin interacting-heads motif (IHM), where both ATPases were inhibited explaining relaxation (Nature 436: 1195, 2005). Their showing that IHM is conserved since before the origin of animals revealed IHM importance as a relaxation ATPase inhibition and ATP energy-saving mechanism. They proposed a cooperative phosphorylation activation mechanism that explains potentiation and post-tetanic potentiation on tarantula contracting muscles. They found that hypertrophic cardiomyopathy mutations cluster on IHM intramolecular interactions accounting for hypercontractility, reduced relaxation, and increased energy consumption of this pathogenesis. Honors: 1991 Polar Prize, 2008 Science and Technology National Prize of Venezuela. Elected Member of the Latin-American Academy of Sciences in 2002 and International Member of the National Academy of Sciences of the U.S.A. in 2018.

Paul Teng is Managing Director and Dean at the National Institute of Education International Pte. Ltd., Singapore; and concurrently senior fellow (food security), Rajaratnam School of International Studies, NTU. He also holds honorary appointments as Adjunct Professor, Murdoch University and Senior Fellow, Southeast Asian Regional Center for Research & Graduate Studies in Agriculture. He is Chair, board of trustees, International Service for Acquisition of Agribiotech Applications (ISAAA) and chairman of the board, Asia BioBusiness Pte. Ltd.. He graduated from Lincoln University, New Zealand, with a BSc in agricultural science (first class honours, 1972) and PhD in 1978. His honours include: CGIAR Excellence in Science Award, 2001; Outstanding Scientific Article; Eriksson Prize for Plant Pathology, Royal Swedish Academy of Sciences; Fellow, American Phytopathological Society; Honorary Doctor of Science, Murdoch University, Australia. Current interests are in andragogy, food security, urban agriculture, biotechnology, sustainability and inclusive agribusiness.

Littlewood took a BA in 1976 and a PhD in physics at the Cavendish Laboratory, Cambridge in 1980, with a one-year intermediate sojourn at MIT as a Kennedy Scholar. In 1980 he moved to Bell Laboratories in Murray Hill, New Jersey, and remained as a member of technical staff to become head of the Theoretical Physics Research Department in 1992. He returned to Cambridge in 1997 as Professor of Physics, and from 2005 to 2010 he was head of the Cavendish Laboratory. In 2011 he became Associate Laboratory Director at Argonne National Laboratory in the USA, and in 2014 Laboratory Director, retiring in 2017. He is a Professor of Physics at the University of Chicago. He is a fellow of the Royal Society of London, Institute of Physics, American Physical Society, and Trinity College Cambridge. He has extensive collaborations in India, at Bangalore, TIFR, and Kolkata. He has over 200 publications and six patents.

Dr Peter Singer has dedicated his career to building innovative institutions with high social impact. Since 2017, he has been Special Advisor to the Director General, supporting Dr Tedros to transform WHO into an Organization focused on measurable impact in countries. Dr Singer co-chaired the transition team; was the architect of WHO’s strategy and its “triple billion” target; supports strategy implementation; and during the pandemic was a strong advocate for vaccine equity. From 2008-2018 Singer was Chief Executive Officer of Grand Challenges Canada, and from 1996-2006 he was Sun Life Financial Chair and Director of the University of Toronto Joint Centre for Bioethics. He is Professor of Medicine at University of Toronto In 2011, Dr Singer was appointed an Officer of the Order of Canada, recognized for his contributions to health research and bioethics and for his dedication to improving the health of people in developing countries, and in 2007 he received the Michael Smith Prize as Canada's Health Researcher of the Year. He is a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, U.S. National Academy of Medicine, and TWAS.

Kwon is professor emeritus, School of Electrical and Computer Engineering, Seoul Natl. Univ. (SNU), where he was prof. from 1977 to 2008; chaired professor of Daegu Gyeongbuk Inst. of Science and Tech. (DGIST) from 2010 to 2014; visiting chair professor of DGIST since 2014. He obtained his BS (1966) and MS (1972) from SNU, and a PhD (1975) from Brown Univ. (BU). He received the Natl. Academy of Sciences Award, 1997; BU Engineering Alumni Medal Award, 2003; and Korea Highest Scientist and Engineer Award, 2007. He is a fellow of IEEE, 1999; National Acad. of Engineering of Korea (NAEK), 1995; Korean Academy of Science and Technology (KAST), 1998; and Intl. Federation of Automatic Control (IFAC), 2010. He was President of Institute of Control, Robotics and Systems (ICROS), 1999; Korean Institute of Electrical Engineers (KIEE), 2001; and IFAC, 2005-08. He was also vice president of NAEK, 2002-06; and vice president of KAST, 2007-10.

Suresh is President, Nanyang Technological U., Singapore. Previously, he served as Pres., Carnegie Mellon U. (2013-17), Dir., Natl. Science Foundation of the United States (2010-13), and as dean of engineering (2007-2010) and Vannevar Bush prof. of engineering, Massachusetts Inst. of Technology (MIT). He received his bachelor of technology (1977) from Indian Inst. of Technology, Madras; MS (1979) from Iowa State U.; and ScD (1981) from MIT. He is world renowned for his pioneering work on the mechanical properties of engineered and biological materials and for establishing connections between cell mechanics and human diseases. He has authored over 240 research articles, 20 patents and 3 books. A recipient of 11 hon. doctorates, he has been elected to 15 engineering/science academies incl. the US Natl. Acad. of Engineering, Natl. Acad. of Sciences, National Academy of Medicine, National Academy of Inventors, and the American Acad. of Arts and Sciences, as well as the French, Chinese and German science academies.

Daar is Prof. of clinical pub. health/global health/surgery at the Univ. of Toronto (UofT). He is member of UN Sec General's Sci Adv Brd. Went to med such in Uganda and London and obtained his PHD (DPhil) in transplant immunology/immunogenetics at Oxford U. In the Middle East, he helped start two med. schools. He has recently been found. chair, Global Alliance for Chronic Diseases (2009-11) and was chair, Adv. Board, UN Univ. Intl. Inst. for Global Health. He was member, UNESCO Intl. Bioethics Comm. He holds the world record for performing the youngest cadaveric donor kidney transplant. His awards include UNESCO Avicenna Prize for Ethics in Science, Hunterian Prof., Roy Col. Surgeons and Anthony Miller Prize for Research Excellence at UofT. He chairs the Sci and Strategic Adv Brd of AESA. His current research studies how to avoid knowledge divides and the exploration of how genomics and other biotechnologies can be used effectively to ameliorate global health inequities.

Professor Moncada’s scientific career began at the Royal College of Surgeons, where he was part of the team that discovered the mechanism of action of aspirin-like drugs, thus explaining how they act to relieve pain, control temperature, reduce inflammation and cause gastric damage. During his time at the Wellcome Research Laboratories he led the team that discovered thromboxane synthase and the vasodilator prostacyclin. This work is the basis for the understanding of how low doses of aspirin prevent cardiovascular cardiovascular disease and events such as heart attacks and strokes. In the 1980’s he discovered nitric oxide as a biological mediator, the mechanism of its biosynthesis and many of its biological functions. As Director of Research at Wellcome, he also presided over the work that resulted in the development of several new medicines, including Lamotrigine, Atovaquone, Somig and La

Lehn, at the University of Strasbourg, France, is Professor at the Institute of Advanced Study, Chair of Chemistry of Complex Systems, and Hemeritus Professor. He is also Honorary Professor at the Collège de France, Paris, where he has been since 1979. From 1970 to 1979, he was Professor of Chemistry at the Université Louis Pasteur in Strasbourg. In 1987, he was awarded the Nobel Prize in Chemistry, together with Donald Cram and Charles J. Pedersen, for his studies on the chemical basis of molecular recognition, which also plays a fundamental role in biological processes. His work led to the definition of a new field of chemistry, which he defined as 'supramolecular' chemistry and deals with the complex entities formed by the association of two or more chemical species held together by non-covalent inter-molecular forces. He is author of more than 990 scientific publications and is a member of many academies, institutions and several industrial bodies. He received numerous international honours and awards.